BRCA mutation status determines bevacizumab efficacy in advanced high-grade serous ovarian cancer

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Marwa Aboalsoud, Zeinab Fathy Abdallah, Rabab Ahmed Moussa, Eman E. Farghal, Asmaa Mohamed Elkady

DOI: 10.1016/j.ijgc.2025.103973

Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy BRCA gene mutations in cancer